On November 20, 2018 Bristol-Myers Squibb Company (NYSE:BMY) reported that it will take part in the Evercore ISI HealthCONx Conference on Tuesday, November 27, 2018, in Boston (Press release, Bristol-Myers Squibb, NOV 20, 2018, https://news.bms.com/press-release/corporatefinancial-news/bristol-myers-squibb-take-part-evercore-isi-healthconx-confere [SID1234531566]). Johanna Mercier, head of U.S. and Large Markets, Worldwide Commercial, will answer questions about the company at 11:45 a.m. ET.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Investors and the general public are invited to listen to a live webcast of the session at View Source Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.